Moderna to Host Investor Event - Analyst Day
-
Snapchat begins age checks in Australia ahead of social media ban
-
Ukrainian sumo wrestler shocked to win first title
-
Shai scores 37 as NBA-best Thunder avenge lone loss
-
McCullum tells England fans to 'keep the faith' after Perth capitulation
-
UK far-right figures stoke digital ID fears with unproven claims
-
Messi magic as Miami thrash Cincinnati, face NYCFC next
-
Asian stocks rise as US rate hopes soothe nerves after torrid week
-
Rising from the ashes: Mogadishu's building boom
-
Ronaldo, 40, scores spectacular bicycle kick
-
New Zealand's Williamson back for West Indies Tests
-
Washington, Kyiv say a peace deal must 'fully uphold' Ukraine sovereignty
-
EU, Africa leaders to talk trade and minerals, as Ukraine looms large
-
Rhino horn sales, shark protection on wildlife talks agenda
-
Mexico training ship that hit Brooklyn Bridge returns home
-
Messi magic as 'perfect' Miami thrash Cincinnati
-
Despite doubts over economy, Americans set for record holiday spending
-
Messi magic sends Miami into MLS conference final
-
Australian mining giant BHP drops Anglo American takeover bid
-
Real Madrid drop points at Elche, Atletico scrape win
-
Bellingham rescues Real Madrid draw at Elche
-
Mahomes rescue act saves Chiefs as Colts stumble
-
Finland's Valimaki wins first PGA title at RSM Classic
-
Pulisic fires AC Milan to derby glory as Roma move top of Serie A
-
50 children in Nigeria escape after kidnapping as 38 worshippers rescued
-
Giroud brace earns Lille win over Paris FC in Ligue 1
-
US says 'very optimistic' on Ukraine plan as Geneva talks end
-
No.1 Jeeno defends title at LPGA Tour Championship
-
Slovenia referendum rejects contested assisted dying law
-
Bolsonaro says ankle monitor tampering driven by 'paranoia'
-
Argentina boss Contepomi labels Curry a 'bully' after England loss
-
Sinner-less Italy see off Spain to complete Davis Cup hat-trick
-
'Exceptional' Eze deserved spotlight in Arsenal rout of Spurs: Arteta
-
Atletico snatch late win at Getafe with own-goal
-
US, Ukraine envoys hail 'good progress' at talks to end Russia war
-
Italy see off Spain to complete Davis Cup hat-trick
-
Arsenal's Eze revels in 'special' hat-trick after destroying Spurs
-
Ouedraogo stunner sends Leipzig second in Bundesliga
-
Ojomoh stars as England edge Argentina for 11th win in a row
-
Eze treble fuels Arsenal's derby rout of Spurs
-
'Wicked' sequel sees green in weekend-winning N. America debut
-
Ojomoh stars as England edge Argentina in Twickenham thriller
-
Israel says killed Hezbollah chief of staff in Beirut strike
-
Roma take top spot in Serie A ahead of Milan derby
-
Berrettini puts Italy on verge of third straight Davis Cup triumph
-
Trump blasts Ukraine for 'zero gratitude' amid talks to halt war
-
Ouedraogo stunner sends Leipzig second
-
What does US 'terrorist' designation for Venezuela mean?
-
Israel targets Hezbollah chief of staff in deadly Beirut strike
-
Scotland thrash Tonga in Autumn Nations finale
-
Three key Irish takeaways from Autumn Nations Series
Moderna to Host Investor Event - Analyst Day
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.
The event will include presentations from management discussing Moderna's development and commercial strategy and key business considerations.
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website
Webcast: investors.modernatx.com.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including pioneering work on COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
P.M.Smith--AMWN
